Resultado de búsqueda
Overview. Post-market surveillance is a set of activities conducted by manufacturers, to collect and evaluate experience gained from medical devices that have been placed on the market, and to identify the need to take any action.
26 de feb. de 2023 · Whether you’re wondering how to get started with PMS for your medical device, or just have a specific question you need answered, this guide is for you. We’re going to cover the basics of postmarket surveillance, as well as the regulations that govern it in both the US and the EU.
2 de abr. de 2020 · Drugs. Guidance, Compliance, & Regulatory Information. Surveillance: Post Drug-Approval Activities. Postmarketing Surveillance Programs. Despite CDER's vigilant premarket review, active...
8 de jun. de 2019 · Postmarketing surveillance refers to the process of monitoring the safety of drugs once they reach the market, after the successful completion of clinical trials. The primary purpose for conducting postmarketing surveillance is to identify previously unrecognized adverse effects as well as positive effects.
This document provides guidance on the post-market surveillance process and is intended for use by medical device manufacturers. This post-market surveillance process is consistent with relevant international standards, in particular ISO 13485 and ISO 14971.
Postmarketing surveillance (PMS), also known as post market surveillance, is the practice of monitoring the safety of a pharmaceutical drug or medical device after it has been released on the market and is an important part of the science of pharmacovigilance.
17 de nov. de 2020 · The guidance emphasizes reactive post-market surveillance through collecting and evaluating feedback, and any required actions to correct and prevent recurrence. It also provides an overview of the market surveillance activities that are the responsibility of National Regulatory Authorities.
